(b)(4) initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).No additional information was provided by the propharma group.Propharma did reach out to obtain with no success.Should additional information be available in the future, the complaint will be re-opened and investigated.All complaints are reviewed during monthly quality/safety meetings.In addition, complaints are trended at monthly quality data analyst meetings and quarterly plant management review meetings.
|
Material no.: unknown, batch no.: unknown.It was reported that the patient experienced an allergic reaction to a chloraprep product.Per email: i had a patient call and state he had an allergic reaction to a chloraprep product.The reaction caused him to extend his hospital stay.He did not know which one, his doctor told him to call our number to find the ingredients in chloraprep.The patients name is [omitted] and he can be reached at [omitted].
|